Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2416426 | 1.00 | KDM4E (0.33) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL346752 | 1.00 | KDM4E (0.33) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL28808090 | 0.97 | KDM1A (0.32) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| Hydrochloric Acid SCHEMBL9168486 | 0.97 | KDM1A (0.32) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| Methacrylic Acid SCHEMBL2015229 | 0.87 | KDM1A (0.32) | KDM4EATMKDM1A | |
| 2-Oxoisohexanoate SCHEMBL28858051 | 0.83 | CA2 (0.35) | KDM1AALDH1A1 | |
| SCHEMBL800041 | 0.82 | — | — | |
| SCHEMBL3161915 | 0.82 | — | — | |
| SCHEMBL5068658 | 0.82 | — | — | |
| SCHEMBL5981771 | 0.81 | TP53 (0.43) | KDM4EGABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 442 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606850-B2 | Synthesis of beta-hydroxyisovalerate and methods of use | Sasya, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| EP-2196225-B2 | Water-soluble agents in acrylate-based preparations | BEIERSDORF AG (DE) | 2025-04-30 | — | — | EP | claimed |
| US-12234495-B2 | Synthesis of beta-hydroxyisovalerate and methods of use | Sasya Inc. (US) | 2025-02-25 | — | — | US | claimed |
| US-20250002949-A1 | SYNTHESIS OF BETA-HYDROXYISOVALERATE AND METHODS OF USE | Sasya Inc. | 2025-01-02 | — | — | US | claimed |
| US-11920177-B2 | Synthesis of beta-hydroxyisovalerate and methods of use | Sasya Inc. (US) | 2024-03-05 | — | — | US | claimed |
| EP-4320253-A1 | SYNTHESIS OF BETA-HYDROXYISOVALERATE AND METHODS OF USE | Sasya Inc. (US) | 2024-02-14 | — | — | EP | claimed |
| CN-117500934-A | Synthesis and use method of beta-hydroxyisovalerate | 萨西亚公司 | 2024-02-02 | — | — | CN | claimed |
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| US-20220325304-A1 | SYNTHESIS OF BETA-HYDROXYISOVALERATE AND METHODS OF USE | Sasya Inc. | 2022-10-13 | — | — | US | claimed |
| WO-2022216868-A1 | SYNTHESIS OF BETA-HYDROXYISOVALERATE AND METHODS OF USE | Sasya Inc. (US) | 2022-10-13 | — | — | WO | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| EP-0969793-A1 | FOIL FOR WRAPPING HAIR ENDS | Wella Aktiengesellschaft (DE) | 2000-01-12 | — | — | EP | claimed |
| WO-1999029282-A1 | FOIL FOR WRAPPING HAIR ENDS | WELLA AKTIENGESELLSCHAFT (DE) | 1999-06-17 | — | — | WO | claimed |
| EP-0589430-B1 | Water-absorptive contact lens | MENICON CO LTD (JP) | 1999-06-16 | — | — | EP | claimed |
| EP-0605686-B1 | EMULSION POLYMERS FOR USE IN HAIR FIXATIVES | NAT STARCH CHEM INVEST (US) | 1998-11-11 | — | — | EP | claimed |
| EP-0618262-B1 | Polyacetal resin composition and sliding member | OILES INDUSTRY CO LTD (JP) | 1998-06-03 | — | — | EP | claimed |
| US-5634971-A | AGITATING WITH A MIXTURE OF WATER AND A POLYOXYALKYLENE GLYCOL HAVING A BRANCHED ALCOHOL END GROUP; PRINTING INKS; ANTIAGGLOMERANTS | PETROLITE CORPORATION (US) | 1997-06-03 | — | — | US | claimed |
| EP-0114414-B1 | PROCESS FOR THE PERMANENT WAVING OF NEWLY GROWN HAIR AND COMPOSITION FOR PERFORMING IT | Wella Aktiengesellschaft (DE) | 1988-06-01 | — | — | EP | claimed |
| US-4660580-A | PREFERENTIAL; LIQUID AQUEOUS PRETREATMENT; IMMISCIBLE WITH PERMANENT WAVE SOLUTION | WELLA AKTIENGESELLSCHAFT (DE) | 1987-04-28 | — | — | US | claimed |
| EP-0114414-A1 | Process for the permanent waving of newly grown hair and composition for performing it | Wella Aktiengesellschaft (DE) | 1984-08-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606850-B2 | Synthesis of beta-hydroxyisovalerate and methods of use | CYP51A1, CYP4Z1, CYP2U1 | KDM4E 959/4885GABRP 616/4885GABRD 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.